Ethics code: 0
Mirahmadi Houtki H, Dehdashti M, Khoshnegah Z, Nejad Shahbodaghi A, Hatami K, Zeighaminezhad F, et al . Prenatal Diagnostic Methods for Inherited Hematologic Disorders: A Review of Hemophilia, Thalassemia, and Sickle Cell Disease. , bloodj. 2026; 23 (3) :266-274
URL:
http://bloodjournal.ir/article-1-1643-en.html
Hassan Mirahmadi Houtki

,
Mehrad Dehdashti

,
Zahra Khoshnegah

,
Aida Nejad Shahbodaghi

,
Khatere Hatami

,
Fatemeh Zeighaminezhad

,
Reyhaneh Hosseini

,
Hajar Mardani Valandani

,
Ali Afgar

,
Tahereh Haghpanah

,
Roohollah Mirzaee Khalilabadi *
Abstract: (3 Views)
A B S T R A C T
Background and Objectives
Hemophilia, thalassemia, and sickle cell disease (SCD) are inherited hematologic disorders associated with important clinical consequences. Prenatal diagnosis can clarify the risk of disease transmission for families and inform clinical and reproductive decisions. Despite advances in molecular diagnosis, the choice of diagnostic approach depends on the type of genetic variation, gestational age, specimen quality, and availability of appropriate technologies. This narrative review summarizes prenatal diagnostic methods for the three aforementioned disorders focusing on their underlying principles, clinical applications and limitations.
Materials and Methods
English-language articles published between 2000 and 2025 were searched in PubMed, Scopus, and Web of Science. Earlier key publications were also consulted to provide historical context. The review covered carrier screening, fetal sampling, molecular assays, cell-free fetal DNA-based non-invasive diagnosis, and preimplantation genetic testing, no formal assessment of methodological quality was performed.
Results
Chorionic villus sampling and amniocentesis remain established approaches for obtaining fetal material for molecular diagnosis. The selection of molecular assays, including allele-specific PCR, Gap-PCR, linkage analysis, sequencing, and copy-number assays depends on the nature of the variant type. Droplet digital PCR and targeted sequencing of cell-free fetal DNA have shown promise in selected setting. However, their clinical application remains constrained by low fetal DNA fractions, discrimination of maternal and fetal alleles, and limited clinical evidence. Preimplantation genetic testing is an alternative option for eligible couples before pregnancy.
Conclusions
An appropriate diagnostic strategy integrates carrier identification, genetic counseling, and selection of a test suited to the causal genetic variant and clinical context. Non-invasive approaches and advanced sequencing technologies hold promise for future applications, but their clinical use should be guided by available evidence and assay-specific validation.
Type of Study:
Review Article |
Subject:
Hematology